Effective acute pain management remains a challenge. Etoricoxib, a selective COX-2 inhibitor, is known for its favorable safety profile compared to traditional NSAIDs. While oral etoricoxib is well-established for pain management, the intramuscular (IM) formulation remains underrepresented in the published literature and warrants further clinical investigation
To compare the safety and efficacy of glimepiride and vildagliptin as add‑on therapy to metformin in newly diagnosed patients with type 2 diabetes mellitus (T2DM).